Godavari Drugs: Statement on Fund Utilization Deviation for Q1 FY27

Godavari Drugs Ltd has submitted its Statement on Deviation or Variation in Utilisation of Funds for the quarter ended June 30, 2026. This statement was reviewed and approved by the Board of Directors during their meeting on August 14, 2026. The company has filed this statement along with the outcome of the board meeting with the stock exchange for information and record purposes. The filing adheres to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.